Recent advances in oncology continue to offer optimism for patients. Investigators are intensely exploring novel approaches, including immune therapies , targeted treatments , and precision medicine . A key study published this week showcases the efficacy of a emerging drug in managing late-stage NSCLC. Furthermore, continued studies are concentrat